Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded
- Contract number
- SPE2DB26FKRWH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,830
Award facts
- Contract value 100% obligated
- $11,830.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,830 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Skyrizi 360 mg/2.4 mL on-body applicators on October 30, 2025, with completion scheduled for November 21, 2025. This competitively awarded, non-set-aside contract represents a single delivery order for the pharmaceutical product to be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a critical pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a major vendor within the federal medical supply chain, particularly supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability to meet rigorous federal procurement standards through open competition, with this award contributing to the Defense Logistics Agency's broader objective of ensuring reliable pharmaceutical access across the Department of Defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2DB26FKRWH?
SPE2DB26FKRWH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FKRWH worth?
The government has obligated $11,830 on SPE2DB26FKRWH.
Is contract SPE2DB26FKRWH an order under another contract?
Yes. SPE2DB26FKRWH is a delivery order under SPE2DB24D3014, an indefinite delivery contract.
Was contract SPE2DB26FKRWH competed?
The extent of competition for SPE2DB26FKRWH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award